HOME Press Releases Microcarriers Market worth 1.61 billion USD by 2023



Microcarriers Market worth 1.61 billion USD by 2023


The report "Microcarrier Market by Equipment (Bioreactor, Culture Vessels, Cell Counter, Filtration System), Consumables (Sera, Serum Free Media), Microcarriers (Cationic, Collagen, Protein coated), Application (Vaccines, Cell Therapy) - Global Forecast to 2023", The microcarriers market is projected to reach USD 1.61 billion by 2023 from USD 1.20 billion in 2018, at a CAGR of 6.0%. Growth in this market is driven by the rising demand for cell-based vaccines, technological advancements, and the availability of public and private funding for cell-based research.

Browse 150 market data Tables and 34 Figures spread through 180 Pages and in-depth TOC on "Microcarrier Market by Equipment (Bioreactor, Culture Vessels, Cell Counter, Filtration System), Consumables (Sera, Serum Free Media), Microcarriers (Cationic, Collagen, Protein coated), Application (Vaccines, Cell Therapy) - Global Forecast to 2023"
https://www.marketsandmarkets.com/Market-Reports/microcarrier-market-139831731.html
Early buyers will receive 10% customization on reports.

Media dominated the microcarriers consumables market in 2017

On the basis of products, the market is segmented into equipment and consumables. The consumables market is further segmented into media, reagents and microcarrier beads. In 2017, the media segment accounted for the largest share of the market. The dominant share of this segment can be attributed to the increased use of serum and basic media in various processes of microcarrier-based culture and the high cost of serum-free media.

By application, the vaccine manufacturing segment held the largest share of the microcarriers market in 2017

The microcarriers market is segmented by application into vaccine manufacturing, cell therapy, and other applications. In 2017, the vaccine manufacturing segment accounted for the largest share of the microcarriers market due to the high and growing demand for cell-based vaccines.

Pharmaceutical and biotechnology companies were the largest end users of microcarriers in 2017

Based on end users, the microcarriers market is segmented into pharmaceutical and biotechnology companies research institutes, and CROs. In 2017, the pharmaceutical and biotechnology companies segment accounted for the largest share of the microcarriers market. The large share of this segment can be attributed to the growing use of single-use technologies in vaccine production, increasing demand for cell-based vaccines, widening application areas of microcarriers, and increasing pharmaceutical R&D expenditure.

Europe dominated the market in 2017

In 2017, Europe dominated the global microcarriers market. The large share of this regional segment can be attributed to factors such as the increasing incidence of cancer, growing number of venture capital investments, availability of technologically advanced products, and strategic expansion of biopharmaceutical companies in this region.

The key players in the microcarriers market are Thermo Fisher Scientific (US), Merck KGaA (Germany), and GE Healthcare (US), Danaher Corporation (US), Corning Incorporated (US), Lonza (Switzerland), Becton, Dickinson and Company (US), Eppendorf AG (Germany), HiMedia Laboratories (India), and Sartorius AG (Germany).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

We will organize an analyst call and demonstrate the latent opportunities and threats which will likely impact your business, at no cost.

Speak to Analyst


* Name :
* Business Email :
* Phone :
* Designation :
* Country:
Report BT 6423: Microcarrier Market by Equipment (Bioreactor, Culture Vessels, Cell Counter, Filtration System), Consumables (Sera, Serum Free Media), Microcarriers (Cationic, Collagen, Protein coated), Application (Vaccines, Cell Therapy) - Global Forecast to 2023
* Enter the text from the image
   to the textbox :
6 7 6 7 5  
Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports